Your browser doesn't support javascript.
loading
Unlocking the potential of established products: toward new incentives rewarding innovation in Europe.
Nayroles, Gabrielle; Frybourg, Sandrine; Gabriel, Sylvie; Kornfeld, Åsa; Antoñanzas-Villar, Fernando; Espín, Jaime; Jommi, Claudio; Martini, Nello; de Pouvourville, Gérard; Tolley, Keith; Wasem, Jürgen; Toumi, Mondher.
Afiliação
  • Nayroles G; Global Market Access and Pricing, IPSEN Pharma, Boulogne-Billancourt, France.
  • Frybourg S; Pricing, Reimbursement and Market Access, Creativ-Ceutical, Paris, France.
  • Gabriel S; Global Market Access and Pricing, IPSEN Pharma, Boulogne-Billancourt, France.
  • Kornfeld Å; Pricing, Reimbursement and Market Access, Creativ-Ceutical, Paris, France.
  • Antoñanzas-Villar F; Department of Economy and Business, University of La Rioja, Logroño, Spain.
  • Espín J; Andalusian School of Public Health, Granada, Spain.
  • Jommi C; Department of Pharmaceutical Sciences, University of Eastern Piedmont, Novara, Italy.
  • Martini N; Centre for Research on Health and Social Care Management (CERGAS), Bocconi University, Milan, Italy.
  • de Pouvourville G; Drugs & Health, Rome, Italy.
  • Tolley K; Department of Economics, ESSEC Business School , Cergy-Pontoise, France.
  • Wasem J; Tolley Health Economics Ltd, Buxton, UK.
  • Toumi M; Department of Economics, University Duisburg-Essen, Essen, Germany.
J Mark Access Health Policy ; 5(1): 1298190, 2017.
Article em En | MEDLINE | ID: mdl-28740616

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article